Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 7.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 2000 to 2009

Recipients with Pancreas After Kidney (PAK) Transplants

  Year of Transplant
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Functioning Graft at Discharge 278 287 336 315 380 306 255 240 192 183
With Immunosuppression Info 277 286 335 312 375 303 249 230 191 178
Corticosteroids Any in Category 95.7% 93.4% 89.9% 80.8% 74.7% 66.7% 63.9% 57.8% 60.2% 59.6%
Steroids 95.7% 93.4% 89.9% 80.8% 74.7% 66.7% 63.9% 57.8% 60.2% 59.6%
Cyclosporine Any in Category 13.7% 9.8% 11.3% 8.3% 8.3% 6.6% 5.6% 4.8% 3.7% 3.9%
Sandimmmune 2.2% 0.7% 0.6% 0.3% 0.5% 0.3% 0.0% 1.7% 0.0% 0.0%
Neoral 11.6% 8.0% 9.0% 6.1% 5.6% 5.9% 5.2% 3.0% 3.1% 2.8%
Gengraf 0.0% 1.0% 1.8% 1.9% 2.1% 0.3% 0.4% 0.0% 0.5% 1.1%
Tacrolimus Any in Category 85.2% 90.6% 86.3% 80.8% 79.7% 85.5% 92.0% 93.5% 93.2% 93.8%
Tacrolimus 85.2% 90.6% 86.3% 80.8% 79.7% 85.5% 92.0% 93.0% 92.7% 93.8%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.4% 0.5% 0.0%
Antimetabolites Any in Category 82.3% 75.5% 74.3% 85.6% 80.3% 83.8% 84.3% 94.3% 93.7% 94.9%
Mycophenolate Mofetil 80.5% 74.1% 74.0% 84.9% 78.9% 79.5% 74.3% 83.9% 79.1% 73.6%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 1.1% 3.3% 9.6% 9.1% 13.1% 20.8%
Azathioprine 1.8% 1.4% 0.3% 0.6% 0.3% 1.0% 0.4% 1.3% 1.0% 0.6%
Leflunomide 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.5% 0.0%
mTOR Inhibitors Any in Category 8.3% 22.0% 19.4% 14.7% 16.3% 13.9% 15.7% 7.8% 7.9% 7.3%
Sirolimus 8.3% 22.0% 19.4% 14.7% 16.3% 13.9% 15.7% 7.8% 7.9% 7.3%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.